Navigation Links
OrthoDynamix LLC Receives FDA 510(k) Clearance for ArthroSteer(R) 3.5mm Ablator
Date:3/2/2010

JACKSONVILLE, Fla., March 2 /PRNewswire/ -- OrthoDynamix announced today that it has received FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip.

Approximately 40 million Americans are affected by joint pain due to multifactorial causes.  There are over 1 million annual surgical interventions of the knee with over 300,000 shoulder and hip procedures.

ArthroSteer's patent pending technology improves triangulation and or orientation of its instruments in tight joint capsules enabling the surgeon greater access to damaged tissue.  The 3.5mm and/or its 5mm high dexterity instruments have surgeon controlled 180 degree bend of the distal shaft while the tip can rotate 360 degrees on its axis, independent of the shaft.

"ArthroSteer's 3.5mm Ablator FDA clearance is an important step for increased sales opportunity in the US," said Bill Dennis, CEO of OrthoDynamix.  "This product complements our unique sports medicine portfolio of steerable ArthroSteer Punch, Grasper and Biter that are currently marketed in the US.  This product portfolio is also being readied for the global market upon receipt of their CE mark."

Advanced and differentiated products for sports medicine, the ArthroSteer's 3.5mm Ablator is designed to withstand the rigors of arthroscopy.  It is also designed for cost savings since it interfaces with many of the hospital's current mono polar electrosurgical generators, thus additional capital equipment is not required.  

About OrthoDynamix LLC

Based in Jacksonville, Florida, OrthoDynamix is a privately held medical device company dedicated to the development and commercialization of the next generation of steerable sports medicine devices.   The minimally invasive product line is designed to address pain issues from pre-arthritis and sport injuries.

CONTACT:  Bill Dennis at OrthoDynamix, 904-641-2599

SOURCE OrthoDynamix LLC

Back to top
'/>"/>
SOURCE OrthoDynamix LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. OrthoDynamix LLC Launches ArthroSteer(TM): Reaching New Limits in Arthroscopy
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... , ... Discover the Rocky Mountain region’s longest running and impressive garden and ... also get to see the most incredible gardens and home improvement experts that attend ... Colorado Convention Center - 700 14th St. Denver CO, is an exciting event that ...
(Date:2/8/2016)... Nevada (PRWEB) , ... February 08, 2016 , ... ... RowdMap, Inc., will be speaking on how healthcare companies can use newly released ... manage the health of a population and intervene and capture the value they ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This ... an estimated 5000 perioperative nurses in attendance to study the latest evidence-based ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 ... addition of the "Global Skin Protective Equipment ... --> http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced ... Equipment Market 2016-2020" report to their offering. ... ( http://www.researchandmarkets.com/research/fqx6nz/global_skin ) has announced the addition of ...
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
Breaking Medicine Technology: